Prostate Biopsy: The Transperineal Approach{A figure is presented}

EAU-EBU Update Series

Volumn 5, Issue 6, 2007, Pages 241-249

  Galfano, Antonio ^a   Novara, Giacomo ^a   Iafrate, Massimo ^a   Cosentino, Marco ^a   Cavalleri, Stefano ^a   Artibani, Walter ^a   Ficarra, Vincenzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Prostate biopsy; Prostate cancer; Transperineal; Transrectal; TRUS

Indexed keywords

AMPICILLIN; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; PROSTATE SPECIFIC ANTIGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIGEN DETECTION; BACTERIAL INFECTION; BIOPSY TECHNIQUE; BRACHYTHERAPY; DIAGNOSTIC VALUE; FEVER; GENERAL ANESTHESIA; HEMATURIA; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LOCAL ANESTHESIA; MEDICAL LITERATURE; MEDLINE; NERVE BLOCK; PATIENT SAFETY; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; SAMPLING; SPINAL ANESTHESIA; TRANSRECTAL ULTRASONOGRAPHY; URINE RETENTION;

EID: 35448993570     PISSN: 18712592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eeus.2007.08.001     Document Type: Review

References (49)

1. Wangensteen O.H., and Wangensteen S.D. Lithotomy and lithotomists. The rise of surgery from empiric craft to scientific discipline (1978), University of Minnesota Press, Minneapolis, MN 71-80
2. Barringer B.S. Carcinoma of the prostate. Surg Gynecol Obstet 34 (1922) 168-176
3. Daves J.A., Tomskey G.C., and Cohen A.E. Transrectal needle biopsy of the prostate. J Urol 85 (1961) 180-182
4. Hodge K.K., McNeal J.E., Terris M.K., and Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71-74
5. Shandera K.C., Thibault G.P., and Deshon Jr. G.E. Variability in patient preparation for prostate biopsy among American urologists. Urology 52 (1998) 644-646
6. Noguchi M., Matsuoka K., Koga H., Kanetake H., Nakagawa M., and Naito S. A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan. Int J Clin Oncol 11 (2006) 390-395
7. Vis A.N., Boerma M.O., Ciatto S., Hoedemaeker R.F., Schroder F.H., and van der Kwast T.H. Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy. Urology 56 (2000) 617-621
8. Emiliozzi P., Scarpone P., DePaula F., et al. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy. J Urol 171 (2004) 197-199
9. Satoh T., Matsumoto K., Fujita T., et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 66 (2005) 114-118
10. Emiliozzi P., Corsetti A., Tassi B., Federico G., Martini M., and Pansadoro V. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 61 (2003) 961-966
11. Phillips B, Ball C, Sackett D, et al. Levels of evidence and grades of recommendation. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/levels_of_evidence.asp#levels. Accessed May 2007.
12. Novella G., Ficarra V., Galfano A., et al. Pain assessment after original transperineal prostate biopsy using a coaxial needle. Urology 62 (2003) 689-692
13. Ficarra V., Novella G., Novara G., et al. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur Urol 48 (2005) 932-937
14. Kawakami S., Okuno T., Yonese J., et al. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy. Eur Urol 51 (2007) 675-683
15. Takenaka A., Hara R., Hyodo Y., et al. Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores. Int J Urol 13 (2006) 10-14
16. Watanabe M., Hayashi T., Tsushima T., Irie S., Kaneshige T., and Kumon H. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol 12 (2005) 959-963
17. Crawford E.D., Wilson S.S., Torkko K.C., et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int 96 (2005) 999-1004
18. Naber K.G., Bergman B., Bishop M.C., et al., Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 40 (2001) 576-588
19. Prayer-Galetti T., Ficarra V., Franceschini R., Liguori G., Martino P., Schiavina R., and Gruppo Italiano Biopsia Prostatica. When to carry out prostate biopsy. Arch Ital Urol Androl 77 3 suppl 1 (2005) 3-16
20. Griffith B.C., Morey A.F., Ali-Khan M.M., Canby-Hagino E., Foley J.P., and Rozanski T.A. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168 (2002) 1021-1023
21. Emiliozzi P., Longhi S., Scarpone P., Pansadoro A., DePaula F., and Pansadoro V. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen. J Urol 166 (2001) 845-850
22. Davis M., Sofer M., Kim S.S., and Soloway M.S. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 167 (2002) 566-570
23. Jeon S.S., Woo S.H., Hyun J.H., Choi H.Y., and Chai S.E. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology 62 (2003) 461-466
24. Herget E.J., Saliken J.C., Donnelly B.J., Gray R.R., Wiseman D., and Brunet G. Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can Assoc Radiol J 50 (1999) 173-176
25. Maan Z., Cutting C.W., Patel U., et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int 91 (2003) 798-800
26. Burger W., Chemnitius J.M., Kneissl G.D., and Rucker G. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 257 (2005) 399-414
27. Masood J., Hafeez A., Calleary J., and Barua J.M. Aspirin use and transrectal ultrasonography-guided prostate biopsy: a national survey. BJU Int 99 (2007) 965-966
28. Halliwell O.T., Lane C., and Dewbury K.C. Transrectal ultrasound-guided biopsy of the prostate: should warfarin be stopped before the procedure? Incidence of bleeding in a further 50 patients. Clin Radiol 61 (2006) 1068-1069
29. Saitoh M., Watanabe M., Iida A., and Watanabe H. Perineal systematic biopsy of the prostate guided by ultrasound. J Med Ultrasound 5 Suppl (1997) 47-50
30. Kojima M., Hayakawa T., Saito T., Mitsuya H., and Hayase Y. Transperineal 12-core systematic biopsy in the detection of prostate cancer. Int J Urol 8 (2001) 301-307
31. Igel T.C., Knight M.K., Young P.R., et al. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J Urol 165 (2001) 1575-1579
32. Kawakami S., Kihara K., Fujii Y., Masuda H., Kobayashi T., and Kageyama Y. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer. Int J Urol 11 (2004) 613-618
33. Bott S.R., Henderson A., Halls J.E., Montgomery B.S., Laing R., and Langley S.E. Extensive transperineal template biopsies of prostate: modified technique and results. Urology 68 (2006) 1037-1041
34. Pepe P., and Aragona F. Prostate needle biopsy: 12 vs. 18 cores- is it necessary?. Urol Int 74 (2005) 19-22
35. Yamamoto S., Kin U., Nakamura K., et al. Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/ml in Japan. Int J Clin Oncol 10 (2005) 117-121
36. Demura T., Hioka T., Furuno T., et al. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer 103 (2005) 1826-1832
37. Luciani L.G., De Giorgi G., Valotto C., Zanin M., Bierti S., and Zattoni F. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings. Urology 67 (2006) 555-558
38. Kawakami S., Hyochi N., Yonese J., et al. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol 11 (2006) 127-132
39. Moran B.J., Braccioforte M.H., and Conterato D.J. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol 176 (2006) 1376-1381
40. Merrick G.S., Gutman S., Andreini H., et al. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol 52 (2007) 715-724
41. Furuno T., Demura T., Kaneta T., et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 58 (2004) 76-81
42. Rabbani F. Editorial comment on: prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol 52 (2007) 723-724
43. Pinkstaff D.M., Igel T.C., Petrou S.P., Broderick G.A., Wehle M.J., and Young P.R. Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 65 (2005) 735-739
44. Rocco B., de Cobelli O., Leon M.E., et al. Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. Eur Urol 49 (2006) 827-833
45. Walz J., Graefen M., Chun F.K.-H., et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50 (2006) 498-505
46. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368-374
47. Chen M.E., Johnston D.A., Tang K., Babaian R.J., and Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89 (2000) 1800-1809
48. Numao N, Kawakami S, Yokoyama M, et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol. In press. doi:10.1016/j.eururo.2007.01.025.
49. Buskirk S.J., Pinkstaff D.M., Petrou S.P., et al. Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol Biol Phys 59 (2004) 1360-1366